
Allergic diseases, which include asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS), atopic dermatitis (AD), food allergy (FA), allergic keratoconjunctivitis, seriously affect the quality of life of people all over the world. Recently, interleukin-33 (IL-33) has been found to play an important role in these refractory disorders, mainly by inducing T helper (Th) 2 immune responses. This article reviews the mobilization and biological function of IL-33 in allergic disorders, providing novel insights for addressing these hypersensitive conditions.
allergic diseases, Th2-type immunity, target therapy, interleukin-33, Organic chemistry, Review, asthma, Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Up-Regulation, QD241-441, Th2 Cells, Hypersensitivity, Quality of Life, Humans, Signal Transduction
allergic diseases, Th2-type immunity, target therapy, interleukin-33, Organic chemistry, Review, asthma, Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Up-Regulation, QD241-441, Th2 Cells, Hypersensitivity, Quality of Life, Humans, Signal Transduction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 65 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
